Sun Pharma will commercialise and manufacture lerodalcibep in global markets outside the US and China after securing exclusive rights from LIB Therapeutics.
Market Samachar is a news aggregator. This article was originally published by NDTV Profit - Latest. Tap the button above to read the full story on their site.